Interline Therapeutics Raises $92M in Funding
The round was led by Foresite Capital and ARCH Venture Partners.
The company intends to use the funds to expand the research platform and advance six preclinical therapeutic programs.
Co-founded by CEO Zachary Sweeney, Interline Therapeutics is a Foresite Labs incubated company that focuses on systematically elucidating protein communities to define molecular mechanisms of disease.
The company uses genomics, proteomics, structural biology and computational chemistry to systematically map and modulate protein communities. Interline Therapeutics is leveraging recent advancements in these technologies, as well as collaborations with academic groups, to develop a precision medicine platform focused on three essential areas:
Marcia Levine didn’t grow up wanting to be a nurse. It’s a career that found her, providing a direction for the desire she always had to help, to fix things, to care for others.
Syndax Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical and Business Update
- Today announced two of the prior responders from ongoing Phase 1 portion of AUGMENT-101 trial of SNDX-5613 achieved full count recovery bringing CR/CRh rate up to 23% -
- Company on track to initiate pivotal Phase 2 portion of AUGMENT-101 trial in 2Q21 -
- Enrollment of 23 cGVHD patients in Phase 2 expansion cohort testing axatilimab at 1 mg/kg complete; enrollment ongoing in pivotal AGAVE-201 trial of axatilimab in cGVHD -
- Company to host conference call today at 4:30 p.m. ET -
News provided by
Share this article
May 10, 2021 by Aimee Minbiole
Honorary degrees will also go to scholars in the arts, education, and sciences.
Pulitzer Prize-winning historian Annette Gordon-Reed 81 will deliver the main address and receive an honorary degree at Dartmouth s 2021 commencement. (Photo by Tony Rinaldo)
PreviousNext
Annette Gordon-Reed 81, a law scholar, MacArthur Fellow, and Pulitzer Prize-winning historian, will deliver the main address and receive an honorary degree at Dartmouth s 2021 commencement in Memorial Stadium, which starts at 11 a.m. on June 13. We are honored to have Annette Gordon-Reed as our commencement speaker this year, says President Philip J. Hanlon 77. With her groundbreaking scholarship, she joins a cohort of prominent honorary degree recipients whose work in the arts, economics, education, and science is transforming our world for the better.
Mike Reddy for STAT
A new medication for children with a rare and life-threatening cancer called neuroblastoma had a curious path to approval last November: With one exception, all U.S. patients in the clinical trials were treated at Memorial Sloan Kettering Cancer Center. For almost a decade, naxitamab now one of the most expensive drugs on the market, at $733,248 for a six-month regimen was available in the U.S. only at the prestigious New York cancer hospital.
During those years, the hospital used its exclusive access to the experimental antibody treatment to recruit patients, promoting its availability on its website and talking up early trial results at conferences attended by parents. At one such conference, a MSK doctor described it as advantageous to the standard antibody treatment used elsewhere in the U.S., though no comparison studies have been done.